Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CFO Robert Thomas Freeman sold 13,815 shares of the business's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $16.89, for a total value of $233,335.35. Following the completion of the sale, the chief financial officer now owns 1,482,595 shares of the company's stock, valued at approximately $25,041,029.55. This trade represents a 0.92 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Robert Thomas Freeman also recently made the following trade(s):
- On Wednesday, March 12th, Robert Thomas Freeman sold 14,692 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.43, for a total value of $226,697.56.
- On Thursday, March 6th, Robert Thomas Freeman sold 218,295 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total value of $3,390,121.35.
- On Tuesday, March 4th, Robert Thomas Freeman sold 250,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.58, for a total value of $3,895,000.00.
Alignment Healthcare Price Performance
Alignment Healthcare stock traded up $0.43 on Friday, reaching $17.61. The company's stock had a trading volume of 3,358,496 shares, compared to its average volume of 1,428,436. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. The company has a market cap of $3.38 billion, a price-to-earnings ratio of -22.87 and a beta of 1.49. The business's fifty day moving average price is $14.90 and its 200 day moving average price is $12.73. Alignment Healthcare, Inc. has a twelve month low of $4.46 and a twelve month high of $17.76.
Hedge Funds Weigh In On Alignment Healthcare
Institutional investors and hedge funds have recently bought and sold shares of the business. R Squared Ltd acquired a new position in Alignment Healthcare in the fourth quarter worth $55,000. RiverPark Advisors LLC acquired a new position in Alignment Healthcare in the fourth quarter worth $106,000. Tower Research Capital LLC TRC lifted its stake in shares of Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock valued at $119,000 after acquiring an additional 6,286 shares during the period. Ballentine Partners LLC acquired a new position in shares of Alignment Healthcare during the fourth quarter valued at $121,000. Finally, Aigen Investment Management LP acquired a new position in shares of Alignment Healthcare during the fourth quarter valued at $129,000. Institutional investors and hedge funds own 86.19% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts have commented on ALHC shares. Stephens reaffirmed an "overweight" rating and issued a $17.00 price target on shares of Alignment Healthcare in a research report on Monday, February 24th. JPMorgan Chase & Co. boosted their price objective on Alignment Healthcare from $14.00 to $17.00 and gave the company a "neutral" rating in a research report on Thursday, March 6th. William Blair restated an "outperform" rating on shares of Alignment Healthcare in a research report on Friday, February 28th. Bank of America boosted their price objective on Alignment Healthcare from $15.50 to $18.50 and gave the company a "buy" rating in a research report on Tuesday, March 4th. Finally, Piper Sandler upped their price target on Alignment Healthcare from $14.00 to $21.00 and gave the company an "overweight" rating in a research report on Tuesday, March 4th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $14.83.
Check Out Our Latest Report on Alignment Healthcare
Alignment Healthcare Company Profile
(
Get Free Report)
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Read More

Before you consider Alignment Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.
While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.